297: VC turmoil, GLP-1 competition, & the war on recovery
The Readout Loud
00:00
Trends in Venture Capital Financing and Biotech IPOs
The chapter explores the changing landscape of venture capital financing, highlighting a decline in biotech and bio pharma financing in 2023. It discusses the trend of biotech companies staying private longer and the resurgence of biotech IPOs, with a focus on Boundless Bio's public debut and new data on obesity treatments.
Transcript
Play full episode
